Editorial Board

Himanshu Kharkwal
Executive Editor
Pharmacovigilance Scientist, Lead PV Operations, Agenus Therapeutics Lexington, Massachusetts, USA, Molecular Biosciences
The University of Nottingham, USA

HIEP (BEN) NGUYEN
Senior scientist, Aurobindo
USA

Amgad M. Rabie, PhD
Editor-in-Chief
Professor, Head of Drug Discovery & Clinical Research
Mansoura University, Egypt

Submit Manuscript

Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at wmmeditor@medicalsci.org

Table of Contents

About the Journal

Index Copernicus Value 2016: 82.05

National Libray of Medicine [NLM ID] :101634347

The purpose of the Journal of Pharmacovigilance (JP) is to publish quality case reports, original research and review articles about the pharmaceutical intervention safety, side effects and adverse effects as well as medications toxicity. Unintended effects are common yet often times there is lack of qualitative and quantitative data that allows for an accurate assessment of the risk/benefits profile of pharmaceuticals. The Journal of Pharmacovigilance aims to fill this important knowledge gap.

Journal of Pharmacovigilance is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide. The Journal of Pharmacovigilance is an open access peer-reviewed journal. Our full open-access policy, which makes all published material immediately available to the public and it is especially relevant when it comes to information about drugs safety and toxicity.

The Pharmacovigilance Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Pharmacovigilance journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacovigilance Open Access Journal are freely accessible to everyone immediately after publication.

h-index

Articles published in Journal of Pharmacovigilance have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacovigilance has got h-index 25 , which means every article in Journal of Pharmacovigilance has got 25 average citations.

Journal Highlights

Current Issue Highlights